Evidence map›Paper›PMID 23697514›Full record

Trial reportThe New England journal of medicine2013

Results of initial low-dose computed tomographic screening for lung cancer.

National Lung Screening Trial Research Team, Timothy R Church, William C Black, Denise R Aberle, Christine D Berg, Kathy L Clingan, Fenghai Duan, Richard M Fagerstrom, Ilana F Gareen, David S Gierada and 6 more

4 registry-linked trialsOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The New England journal of medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 558 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
558citing papers in PubMed, 6 pooled it
65.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00047385 phase3completednot on this map

National Lung Screening Trial A Randomized Trial Comparing Low-dose Helical CT With Chest Xray for Lung Cancer

TypeinterventionalSponsorNational Cancer Institute (NCI)Ran2002 to 2010Enrolled53,454ConditionsLung CancerArmslow-dose helical computed tomography, chest radiography
NCT02611570 active not recruitingnot on this mapstarted 2014, after this paper: background citation

Low Dose Computed Tomography Screening Study in Non-smokers with Risk Factors for Lung Cancer in Taiwan

TypeobservationalSponsorAcademia Sinica, TaiwanRan2014 to 2028Enrolled12,000ConditionsLung CancerArmsLDCT
NCT03395964 nacompletednot on this mapstarted 2018, after this paper: background citation

Comparison of Preoperative CT Scan Guided and Intraoperative Hybrid DynaCT Scan-Guided Small Lung Tumor Localization: A Randomized Study

TypeinterventionalSponsorChang Gung Memorial HospitalRan2018 to 2020Enrolled54ConditionsSmall and/or Deep Lung TumorArmsHybrid Dyna-CT guided localization, Preoperative CT scan-guided localization
NCT05557487 recruitingnot on this mapstarted 2022, after this paper: background citation

Taiwan Real-world Low-dose Computed Tomography Screening behavIor and Outcome Research for High Risk Subjects Based on Health Promotion Administration-part A: Questionnaire Survey -Part B: LDCT Screening Outcome and Management

TypeobservationalSponsorGee-Chen ChangRan2022 to 2028Enrolled6,618ConditionsLung Cancer, High-Risk Cancer, Smoking, PollutionArmsLow dose computed tomography
3 · Its place in the literature

Who cites it

558 citing papers in PubMed, 6 syntheses or guidelines pooled it, 1,072 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Lung Cancer Screening With Low-Dose Computed Tomography.Deutsches Arzteblatt international · 2023
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

498 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

National Lung Screening Trial Research Team
Timothy R Church
William C Black
Denise R Aberle
Christine D Berg
Kathy L Clingan
Fenghai Duan
Richard M Fagerstrom
Ilana F Gareen
David S Gierada
Gordon C Jones
Irene Mahon
Pamela M Marcus
JoRean D Sicks
Amanda Jain
Sarah Baum
Center for Environmental Health · US

Funding

ARRA - ADOPT New Technologies for RDC/CDMSU01CA080098 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI SCHNALL, MITCHELL D. · 1999 to 2011
$182.7M
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
BIOSTATISTICS DATA MANAGEMENT CENTER FOR ACROINU01CA079778 · NCI · BROWN UNIVERSITY · PI GATSONIS, CONSTANTINE A. · 1999 to 2011
$48.6M
American College of Radiology Imaging NetworkU10CA080098 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI SCHNALL, MITCHELL D. · 2012 to 2013
$9.4M
PROSTATE, LUNG, COLORECTAL, &OVARIAN CANCER SCREENINGN01CN025476 · CN · WESTAT, INC. · PI O'BRIEN, BARBARA B · 1992 to 2000
$7.9M
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCERN01CN025512 · CN · HENRY FORD HEALTH SYSTEM · PI DEMERS, RAYMOND Y · 1992 to 2001
$2.0M
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCERN01CN075022 · CN · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FOUAD, MONA N. · 1997 to 2001
$1.6M
PROSTATE, LUNG, COLORECTAL &OVARIAN (PLCO) CANCERN01CN025516 · CN · WASHINGTON UNIVERSITY · PI ANDRIOLE, GERALD LOUIS · 1992 to 2001
$1.5M
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCERN01CN025524 · CN · UNIVERSITY OF UTAH · PI BUYS, SAUNDRA S · 1992 to 2000
$1.5M
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCERN01CN025514 · CN · UNIVERSITY OF COLORADO DENVER · PI CRAWFORD, E DAVID · 1992 to 2000
$1.3M
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCERN01CN025515 · CN · PACIFIC HEALTH RESEARCH INSTITUTE · PI YOKOCHI, LANCE L · 1992 to 2000
$1.2M
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCERN01CN025511 · CN · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WEISSFELD, JOEL L · 1992 to 2000
$1.2M
NCI NIH HHS N01 CN025476NCI NIH HHS N01 CN025511NCI NIH HHS N01 CN025512NCI NIH HHS N01 CN025513NCI NIH HHS N01 CN025514NCI NIH HHS N01 CN025515NCI NIH HHS N01 CN025516NCI NIH HHS N01 CN025518NCI NIH HHS N01 CN025522NCI NIH HHS N01 CN025524NCI NIH HHS N01 CN075022NCI NIH HHS N01-CN-25476NCI NIH HHS N01-CN-25511NCI NIH HHS N01-CN-25512NCI NIH HHS N01-CN-25513NCI NIH HHS N01-CN-25514NCI NIH HHS N01-CN-25515NCI NIH HHS N01-CN-25516NCI NIH HHS N01-CN-25518NCI NIH HHS N01-CN-25522NCI NIH HHS N01-CN-25524NCI NIH HHS N01-CN-75022NCI NIH HHS N02 CN063300NCI NIH HHS N02-CN-63300NCI NIH HHS P30 CA023108NCI NIH HHS U01 CA079778NCI NIH HHS U01 CA080098NCI NIH HHS U01-CA-79778NCI NIH HHS U01-CA-80098NCI NIH HHS U10 CA080098
6 · The paper itself

Abstract

backgroundLung cancer is the largest contributor to mortality from cancer. The National Lung Screening Trial (NLST) showed that screening with low-dose helical computed tomography (CT) rather than with chest radiography reduced mortality from lung cancer. We describe the screening, diagnosis, and limited treatment results from the initial round of screening in the NLST to inform and improve lung-cancer-screening programs.

methodsAt 33 U.S. centers, from August 2002 through April 2004, we enrolled asymptomatic participants, 55 to 74 years of age, with a history of at least 30 pack-years of smoking. The participants were randomly assigned to undergo annual screening, with the use of either low-dose CT or chest radiography, for 3 years. Nodules or other suspicious findings were classified as positive results. This article reports findings from the initial screening examination.

resultsA total of 53,439 eligible participants were randomly assigned to a study group (26,715 to low-dose CT and 26,724 to chest radiography); 26,309 participants (98.5%) and 26,035 (97.4%), respectively, underwent screening. A total of 7191 participants (27.3%) in the low-dose CT group and 2387 (9.2%) in the radiography group had a positive screening result; in the respective groups, 6369 participants (90.4%) and 2176 (92.7%) had at least one follow-up diagnostic procedure, including imaging in 5717 (81.1%) and 2010 (85.6%) and surgery in 297 (4.2%) and 121 (5.2%). Lung cancer was diagnosed in 292 participants (1.1%) in the low-dose CT group versus 190 (0.7%) in the radiography group (stage 1 in 158 vs. 70 participants and stage IIB to IV in 120 vs. 112). Sensitivity and specificity were 93.8% and 73.4% for low-dose CT and 73.5% and 91.3% for chest radiography, respectively.

conclusionsThe NLST initial screening results are consistent with the existing literature on screening by means of low-dose CT and chest radiography, suggesting that a reduction in mortality from lung cancer is achievable at U.S. screening centers that have staff experienced in chest CT. (Funded by the National Cancer Institute; NLST ClinicalTrials.gov number, NCT00047385.).

Indexed as

Radiography, ThoracicTomography, X-Ray ComputedAgedEarly Detection of CancerFemaleHumansLung NeoplasmsMaleMiddle AgedRadiation DosageSensitivity and SpecificitySmoking

Identifiers

PMID23697514
PMCPMC3762603
OpenAlexW2121203541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.